Carlisle Companies Incorporated
US ˙ NYSE ˙ US1423391002

Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael D Popielec. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Michael D Popielec has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ULBI / Ultralife Corporation Director, President and CEO, Director 0
US:CSL / Carlisle Companies Incorporated Group President 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael D Popielec. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CSL / Carlisle Companies Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CSL / Carlisle Companies Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSL / Carlisle Companies Incorporated Insider Trades
Insider Sales CSL / Carlisle Companies Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CSL / Carlisle Companies Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSL / Carlisle Companies Incorporated Insider Trades
Insider Purchases ULBI / Ultralife Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CSL / Carlisle Companies Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2016-11-04 ULBI POPIELEC MICHAEL D 3,801 4.2000 3,801 4.2000 15,964 346 7.7000 13,304 83.34
2016-11-03 ULBI POPIELEC MICHAEL D 3,900 4.0970 3,900 4.0970 15,978
2016-11-02 ULBI POPIELEC MICHAEL D 400 4.1500 400 4.1500 1,660
2016-11-02 ULBI POPIELEC MICHAEL D 1,899 4.1000 1,899 4.1000 7,786
2013-05-30 ULBI POPIELEC MICHAEL D 10,000 3.8600 10,000 3.8600 38,600
2012-08-07 ULBI POPIELEC MICHAEL D 7,267 2.8995 7,267 2.8995 21,071
2012-08-06 ULBI POPIELEC MICHAEL D 17,733 2.8496 17,733 2.8496 50,532
2012-05-23 ULBI POPIELEC MICHAEL D 2,896 4.1488 2,896 4.1488 12,015
2012-05-22 ULBI POPIELEC MICHAEL D 2,724 4.1489 2,724 4.1489 11,302
2012-05-21 ULBI POPIELEC MICHAEL D 5,855 4.1500 5,855 4.1500 24,298
2012-05-18 ULBI POPIELEC MICHAEL D 4,725 4.1312 4,725 4.1312 19,520
2012-05-17 ULBI POPIELEC MICHAEL D 8,800 4.0529 8,800 4.0529 35,666
2012-05-10 ULBI POPIELEC MICHAEL D 9,500 4.4900 9,500 4.4900 42,655
2012-05-09 ULBI POPIELEC MICHAEL D 15,500 4.3800 15,500 4.3800 67,890
2012-02-23 ULBI POPIELEC MICHAEL D 5,400 4.9164 5,400 4.9164 26,549
2012-02-22 ULBI POPIELEC MICHAEL D 16,100 4.8652 16,100 4.8652 78,330
2012-02-21 ULBI POPIELEC MICHAEL D 18,500 4.6934 18,500 4.6934 86,828

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ULBI / Ultralife Corporation Insider Trades
Insider Sales ULBI / Ultralife Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CSL / Carlisle Companies Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ULBI / Ultralife Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Michael D Popielec as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2021-12-21 2021-12-17 4 ULBI ULTRALIFE CORP
Stock Options 		M - Exercise -20,000 0 -100.00
2021-12-21 2021-12-17 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		M - Exercise 6,583 316,509 2.12 3.79 24,934 1,198,809
2021-10-22 2021-10-20 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 40,000 40,000
2021-08-12 2021-08-10 4 ULBI ULTRALIFE CORP
Stock Options 		M - Exercise -40,000 0 -100.00
2021-08-12 2021-08-10 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		M - Exercise 12,709 309,926 4.28 3.71 47,154 1,149,918
2020-11-24 2020-11-23 4 ULBI ULTRALIFE CORP
Stock Options 		M - Exercise -300,000
2020-11-24 2020-11-23 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		M - Exercise 26,929 297,217 9.96 6.42 172,933 1,908,668
2020-04-23 2020-04-22 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 40,000 40,000
2019-07-25 2019-07-23 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 45,000 45,000
2018-07-27 2011-06-07 4/A ULBI ULTRALIFE CORP
Employee Stock Option (right to buy) 		A - Award 200,000 200,000
2018-04-19 2018-04-18 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 40,000 40,000
2017-04-21 2011-06-07 4/A ULBI ULTRALIFE CORP
Employee Stock Option (right to buy) 		A - Award 250,000 250,000
2017-04-21 2010-12-30 4/A ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		A - Award 50,000 50,000
2016-11-04 2016-11-04 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 3,801 270,288 1.43 4.20 15,964 1,135,210
2016-11-04 2016-11-03 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 3,900 266,487 1.49 4.10 15,978 1,091,797
2016-11-04 2016-11-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 1,899 262,587 0.73 4.10 7,786 1,076,607
2016-11-04 2016-11-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 400 260,688 0.15 4.15 1,660 1,081,855
2016-06-03 2016-06-01 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 40,000 40,000
2015-10-09 2015-10-08 4 ULBI ULTRALIFE CORP
Restricted Stock Units 		J - Other -60,000 0 -100.00
2015-10-09 2015-10-08 4 ULBI ULTRALIFE CORP
Common Stock, $.10 par value 		M - Exercise 39,147 260,288 17.70
2015-03-09 2015-03-05 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 20,000 20,000
2015-03-09 2015-03-03 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy) 		A - Award 40,000 40,000
2015-01-05 2015-01-01 4 ULBI ULTRALIFE CORP
Restricted Stock Units 		J - Other -12,639 60,000 -17.40
2015-01-05 2015-01-01 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		M - Exercise 17,361 221,141 8.52
2014-01-02 2014-01-01 4 ULBI ULTRALIFE CORP
Restricted Stock Units 		J - Other -11,220 90,000 -11.08
2014-01-02 2014-01-01 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		M - Exercise 18,780 203,780 10.15
2013-06-06 2013-06-04 4 ULBI ULTRALIFE CORP
Restricted Stock Units 		A - Award 120,000 120,000
2013-06-03 2013-05-30 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 10,000 185,000 5.71 3.86 38,600 714,100
2012-08-08 2012-08-07 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 7,267 175,000 4.33 2.90 21,071 507,412
2012-08-08 2012-08-06 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 17,733 167,733 11.82 2.85 50,532 477,972
2012-05-24 2012-05-23 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,896 150,000 1.97 4.15 12,015 622,320
2012-05-24 2012-05-22 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 2,724 147,104 1.89 4.15 11,302 610,320
2012-05-21 2012-05-21 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 5,855 144,380 4.23 4.15 24,298 599,177
2012-05-21 2012-05-18 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 4,725 138,525 3.53 4.13 19,520 572,274
2012-05-21 2012-05-17 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 8,800 133,800 7.04 4.05 35,666 542,278
2012-05-10 2012-05-10 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 9,500 125,000 8.23 4.49 42,655 561,250
2012-05-10 2012-05-09 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value 		P - Purchase 15,500 115,500 15.50 4.38 67,890 505,890
2012-02-23 2012-02-23 4 ULBI ULTRALIFE CORP
Common Stock, $.10 par value 		P - Purchase 5,400 100,000 5.71 4.92 26,549 491,640
2012-02-23 2012-02-22 4 ULBI ULTRALIFE CORP
Common Stock, $.10 par value 		P - Purchase 16,100 94,600 20.51 4.87 78,330 460,248
2012-02-23 2012-02-21 4 ULBI ULTRALIFE CORP
Common Stock, $.10 par value 		P - Purchase 18,500 78,500 30.83 4.69 86,828 368,432
2005-09-09 3 CSL CARLISLE COMPANIES INC
Common Stock 		0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)